Ephedrine Sulfate — 50 mg/1 mL, Injection, 1 mL vial, single-dose

Ephedrine Sulfate — 50 mg/1 mL, Injection, 1 mL vial, single-dose

Ephedrine Sulfate is a injection for intravenous use. Ephedrine Sulfate Injection, USP is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. Supplied as 1 mL vial, single-dose; NDC 0641-6238-01; manufacturer Hikma Pharmaceuticals USA Inc. Rx only. Store Ephedrine Sulfate Injection, USP, 50 mg/mL, at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].

• Active ingredient or product type: EPHEDRINE SULFATE
• Strength/concentration: 50 mg/1 mL
• Dosage form and route: Injection, Intravenous
• Exact package presentation: 1 mL vial, single-dose
• NDC/item number: 0641-6238-01
• Manufacturer/labeler: Hikma Pharmaceuticals USA Inc.
• Storage/handling: Store Ephedrine Sulfate Injection, USP, 50 mg/mL, at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Store in carton until time of use.
• Status: Rx only

Important safety information: Pressor Effects with Concomitant Use with Oxytocic Drugs : Pressor effect of sympathomimetic pressor amines is potentiated ( 5.1 ) Tachyphylaxis and Tolerance : Repeated administration of ephedrine may cause tachyphylaxis ( 5.2 ) 5.1 Pressor Effect with Concomitant Oxytocic Drugs Serious postpartum.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.